2022 annual financial data
ADMA Biologics 2022 Operating margin
ADMA Biologics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -25.55%.
Operating income was -39,365,000 USD and net income was -65,904,000 USD.
Operating cash flow was -59,508,257 USD.
Get free ADMA Biologics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 154,080,000 USD
- Operating income
- -39,365,000 USD
- Net income
- -65,904,000 USD
- Operating cash flow
- -59,508,257 USD